The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

Roughly half the world's population is already at risk of contracting the two diseases, which were once mainly confined to ...

Climate change is pushing disease-carrying tiger mosquitoes deeper into Europe, raising the risk that once-tropical viruses ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

The diseases include dengue, chikungunya, zika and yellow fever among others. India experiences a large number of deaths due ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

Early COVID suppression could have prevented 180,000 UK deaths, study reveals … FDA, CDC pause chikungunya vaccine for adults ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty answers questions about the ...